| Dr Stephen J Andrews, MD | |
|
161 N Forge St, Suite 298, Akron, OH 44304-1468 | |
| (330) 379-3514 | |
| (330) 379-9211 |
| Full Name | Dr Stephen J Andrews |
|---|---|
| Gender | Male |
| Speciality | Gynecological Oncology |
| Experience | 39 Years |
| Location | 161 N Forge St, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255328845 | NPI | - | NPPES |
| AN0882131 | Other | OH | MEDICARE ID |
| 2134176 | Medicaid | OH | |
| 0882138 | Other | OH | MEDICARE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 35056479 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summa Health System | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summa Physicians Inc | 2961303532 | 640 |
News Archive
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that it has received notification from the US Food and Drug Administration (FDA) that the Agency is currently drafting a response to the Company relating to the Investigational New Drug (IND) Application it filed in November seeking clearance to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).
Maternal use of valproate (a drug used for the treatment of epilepsy and other neuropsychological disorders) during pregnancy was associated with a significantly increased risk of autism in offspring, according to a study in the April 24 issue of JAMA.
Dyax Corp. announced today that the European Medicines Agency (EMA) has completed its validation process for the Marketing Authorization Application (MAA) for potential approval to market DX-88 (ecallantide) in the European Union (EU).
ORBIS Canada, a non-profit global development organization dedicated to saving sight worldwide, is launching a series of holiday cards available for purchase this season. Proceeds of these cards will be used to build ORBIS Kids Sight treatment centres in the developing world.
› Verified 9 days ago
| Entity Name | Summa Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that it has received notification from the US Food and Drug Administration (FDA) that the Agency is currently drafting a response to the Company relating to the Investigational New Drug (IND) Application it filed in November seeking clearance to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).
Maternal use of valproate (a drug used for the treatment of epilepsy and other neuropsychological disorders) during pregnancy was associated with a significantly increased risk of autism in offspring, according to a study in the April 24 issue of JAMA.
Dyax Corp. announced today that the European Medicines Agency (EMA) has completed its validation process for the Marketing Authorization Application (MAA) for potential approval to market DX-88 (ecallantide) in the European Union (EU).
ORBIS Canada, a non-profit global development organization dedicated to saving sight worldwide, is launching a series of holiday cards available for purchase this season. Proceeds of these cards will be used to build ORBIS Kids Sight treatment centres in the developing world.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen J Andrews, MD 161 N Forge St, Suite 298, Akron, OH 44304-1468 Ph: (330) 379-3514 | Dr Stephen J Andrews, MD 161 N Forge St, Suite 298, Akron, OH 44304-1468 Ph: (330) 379-3514 |
News Archive
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that it has received notification from the US Food and Drug Administration (FDA) that the Agency is currently drafting a response to the Company relating to the Investigational New Drug (IND) Application it filed in November seeking clearance to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).
Maternal use of valproate (a drug used for the treatment of epilepsy and other neuropsychological disorders) during pregnancy was associated with a significantly increased risk of autism in offspring, according to a study in the April 24 issue of JAMA.
Dyax Corp. announced today that the European Medicines Agency (EMA) has completed its validation process for the Marketing Authorization Application (MAA) for potential approval to market DX-88 (ecallantide) in the European Union (EU).
ORBIS Canada, a non-profit global development organization dedicated to saving sight worldwide, is launching a series of holiday cards available for purchase this season. Proceeds of these cards will be used to build ORBIS Kids Sight treatment centres in the developing world.
› Verified 9 days ago
Dr. Amy M Burkett, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-869-0052 | |
David M Nash, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 95 Arch St, Ste 250, Akron, OH 44304 Phone: 330-375-7722 Fax: 330-253-6708 | |
Cecilia A. Ellis, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 605 N Cleveland Massillon Rd, Akron, OH 44333 Phone: 330-668-6545 Fax: 330-668-2726 | |
James Graham, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 919 E Turkeyfoot Lake Rd Ste A, Akron, OH 44312 Phone: 330-899-9626 Fax: 330-633-6068 | |
John A. Black, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1622 E Turkeyfoot Lake Rd, #301, Akron, OH 44312 Phone: 330-344-8565 Fax: 330-896-7085 | |
Dr. Muriel Tabet, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Ste 200, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-865-6011 | |
L Ann Nunnally, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 839 E Market St, Akron, OH 44305 Phone: 330-535-9191 |